Objectives. We attempted to establish a relation between the atrial conduction time assessed by the signal-averaged P wave electrocardiogram and episodes of paroxysmal atrial fibrillation in patients with the Wolff.Parkinson-White syndrome.
In group 2, the signal-averaged P wave duration was 126.64 _+ 8.72 ms (range 111.0 to 136.0). Only one patient in this group (9%) showed a P wave duration > 135.0 ms (p < 0.000, group 1 vs. group 2). The signal-averaged P wave duration in the control group was 124.46 _+ 4.49 ms (range 115.0 to 129.5; p < 0.000, group 1 vs. the control group; p < 0.454, group 2 vs. the control group). The P wave duration in lead II was 92.06 _+ 8.85 ms in group 1 and 9227 ,+ 7.86 ms in group 2 (p < 0.949). Using a cutoff value of < 135.0 ms for a normal signal-averaged P wave duration, the method had a sensitivity and specificity and positive and negative predictive values of 82%, 91%, 93% and 77%, respectively, for identifying patients with clinical paroxysmal atrial fibrillation.
Conclusions. In the current study, the signal-averaged P wave showed a prolonged intraatrial conduction time in patients with the Wolff-Parkinson-White syndrome and paroxysmal atrial fibrillation. These patients can be differentiated from those with the pre-excitation syndrome without clinical atrial fibrillation as well as from normal subjects. The prolonged intraatrial conduction time may serve as an atrial substratum for development and maintenance of the fibrillatory state.
(J Am CoU Cardio11995; 26:1310-4) Patients with the Wolff-Parkinson-White syndrome have a higher incidence of spontaneous paroxysmal atrial fibrillation than that of normal persons (1) . If the properties of the accessory pathway allow rapid conduction, paroxysmal atrial fibrillation can be a potentially life-threatening arrhythmia (2) . Recent work has demonstrated the clinical utility of the signal-averaged P wave electrocardiogram (ECG) in studying atrial activation conduction times. These studies (3, 4) reported that a prolonged signal-averaged P wave duration is associated with high sensitivity and specificity for identifying patients at risk for the development of paroxysmal atrial fibrillation. However, ability to obtain the signal-averaged P wave duration in patients with the Wolff-Parkinson-White syndrome is lim- ited by the presence of the delta wave. When ventricular pre-excitation exists, the delta wave can conceal the end of the P wave, affecting the correct determination of P wave duration. This problem does not occur after successful radiofrequency ablation of the anomalous pathway or during normal conduction in cases of intermittent pre-excitation. In these two situations, the disappearance of the delta wave allows a precise assessment of P wave duration.
The purpose of this study was to evaluate, using the signal-averaged P wave ECG, the intraatrial conduction time of patients with the pre-excitation syndrome who had previously undergone successful radiofrequency catheter ablation. We compared the findings in patients with and without documented episodes of paroxysmal atrial fibrillation and in a control group of normal subjects.
Methods
Patient selection. We prospectively analyzed the signalaveraged P wave ECG of 28 consecutive patients with the ©1995 by the American College of Cardit~logy 0735-1097/95/$9.50 0735-1097(95)00317-W Wolff-Parkinson-White syndrome, with a fixed degree of ventricular pre-excitation, who underwent radiofrequency ablation. There were 18 men and 10 women with a mean age _+ SD of 34.6 _+ 12.0 years; 20 patients had a left-sided and 8 had a right-sided accessory pathway. Group 1 comprised 17 patients (61%; 15 men, 2 women; mean age 35.1 + 10.6 years) with previous documented episodes of paroxysmal atrial fibrillation. In this group, 13 patients had a left-sided anomalous pathway. Group 2 comprised 11 patients (39%; 8 women, 3 men; mean age 33.9 __ 14.4 years) without clinical atrial fibrillation; 7 of these 11 patients had a left-sided accessory pathway. The results in these two groups were compared with the results obtained in an age-matched normal control group of 12 patients (7 women, 5 men; mean age 33.1 _+ 10.2 years).
To preclude left atrial enlargement, we excluded from the study patients with any of the following conditions: 1) congestive heart failure, 2) systemic hypertension (blood pressure ->160/90 mm Hg), 3) previous myocardial infarction, 4) congenital heart disease, 5) cardiomyopathy, 6) systemic diseases. All patients who met these entry criteria had a left atrial size <4.0 cm by echocardiography and were withdrawn from all antiarrhythmic medications at least 5 half-lives before the ablation and the signal-averaged procedures. Individual data are shown in Table 1 .
Accessory pathway ablation. Radiofrequency catheter ablation protocols were approved by the Scientific Board of our institutions. Written informed consent was obtained from all patients. For left-sided anomalous pathways, the procedure was performed by using the retrograde arterial approach, with the catheter positioned on the ventricular side of the mitral annulus. Energy was delivered at sites that recorded the shortest atrioventricular (AV) times. The predictor of success was the interval between the onset of the local ventricular electrogram and the onset of the delta wave in the surface ECG, with or without anomalous pathway potentials, recorded in at least five similar pre-excited beats. For right-sided accesso W pathways, a transvenous femoral approach was used and ablation was performed at the atrial aspect of the tricuspid annulus. In five patients the ablation was performed during paroxysmal atrial fibrillation (5) without interruption of the atrial tachyarrhythmia ( Fig. 1 ). Successful ablation was achieved in all 28 patients studied with the averaged P wave method. The data from the ablation procedures in groups 1 and 2 were compared.
Standard ECG methodology. For each patient, a standard 12-lead ECG was recorded immediately before the signalaveraged P wave. The records were obtained at a paper speed of 25 mm/s and a signal size of 10 mm/mV. The total P wave duration was manually measured in lead II.
Signal-averaged methodology. The signal-averaged P wave was recorded according to the method proposed by Guidera and Steinberg (3) using the Predictor II system from Corazonix Corporation. The recordings were performed between the 7th and the 14th day after the ablation procedure to allow atrial functional recovery time after paroxysmal atrial fibrillation and cardioversion (6) . An orthogonal lead system identical to that used in ventricular signal-averaged ECGs was used (7) . The QRS complex was used as the trigger of the signal-averaging process. To expose the P wave, the fiducial point was shifted to the right at a 450-ms window. The signal was digitized at a frequency of 2,000 samples/s with 16-bit accuracy. A sinus P wave template was manually selected, with a correlation coef- ficient of 99%. The correlation window width was 25 ms, with <0.3-~V noise at the end of the procedure. To improve the visualization of the low amplitude components of the atrial activation, a least square fit filter with a window width of 100 ms was applied to the averaged output. P wave onset and offset were determined manually as the first atrial deflection from the baseline noise level and the return of the atrial signal to the baseline level, respectively. The X, Y and Z filtered leads were combined into a P vector magnitude. The total P wave duration, in ms, was manually determined from the P vector magnitude. Signal-averaged P wave analysis. The signal-averaged P waves were prospectively analyzed in blinded fashion; two different physicians reviewed the data without knowledge of previous clinical paroxysmal atrial fibrillation.
Follow-up. All patients were carefully followed up during outpatient clinic visits, when symptoms that might indicate atrial fibrillation recurrence were investigated. Long-term ablation success was considered achieved if no evidence of recurrences of the clinical arrhythmia or a return of preexcitation were diagnosed.
Statistical analysis. Data arc presented as mean value _+ 1 SD. One-way analysis of variance was used for group comparisons. Significance refers to a value of p < 0.05. The P wave duration from the vector magnitude was used to determine the sensitivity, specificity, and positive and negative predictive values of the signal-averaged P wave for identifying patients with clinical paroxysmal atrial fibrillation.
Results
Baseline clinical data and radiofrequency ablation characteristics. The groups with (group 1) and without (group 2) clinical atrial fibrillation did not differ in age, site of accessory pathway, number of radiofrequency applications required (4.45 _+ 2.54 vs. 3.36 -+ 2.58, p < 0.330) or total delivered energy (110.45 _+ 52.75 vs. 82.91 + 52.72 W, respectively, p < 0.235). P wave duration in standard lead II. P wave duration in lead lI ranged from 85.0 to 120.0 ms (mean 92.06 + 8.85) in group 1 and from 80.0 to 100 ms (mean 92.27 _+ 7.86) in group 2 (p < 0.949). Three patients in group 1 (Cases 1, 25 and 28) and one patient in group 2 (Case 24) showed notched P waves.
Signal-averaged P wave analysis. P wave duration in group 1 ranged from 130.0 to 171.0 ms (mean 14t.94 _+ 9.47); 14 patients (82%) in this group had values >135.0 ms. P wave duration in group 2 ranged from 1tl.0 to 136.0 ms (mean 126.64 _+ 8.72), only one patient (9%) had a value >135.0 ms. In the control group, P wave duration ranged from 114.0 to 129.5 ms (mean 124.46 _ 4.49). Examples of the signalaveraged P wave are shown in Figure 2 and the results are expressed graphically in Figure 3 . The P wave duration comparisons between groups 1 and 2 reached statistical significance (p < 0.000) as did the comparisons between group 1 and the control group (p < 0.000). There were no statistical differences between group 2 and the control group (p < 0.454).
To assess the consequences of radiofrequency application over the atrial tissue, we examined the results of the signalaveraged P wave duration considering only the 20 patients with a left-sided anomalous connection who underwent energy delivery, on the ventricular side of the mitral annulus. Among patients with a left-sided connection in group 1, P wave duration ranged from 130.0 to 152.0 ms (mean 138.42 +_ 5.12); With a cutoff value for normal P wave duration of <135.0 ms, the sensitivity, specificity and positive and negative predictive values of the method were 82%, 91%, 93% and 77% respectively, for identifying patients with clinical paroxysmal atrial fibrillation. P wave in lead II and signal-averaged P wave. In all patients, P wave duration after signal averaging was significantly longer than P wave duration measured in standard lead II. In group 1, the increase in P wave duration ranged from 43.5 to 62.0 ms (mean 50.15 _+ 5.82). In group 2, it ranged from 21.0 to 42.0 ms (mean 34.36 ___ 5.35) (p < 0.000). In the control group, it ranged from 25.0 to 42.0 ms (mean 35.67 __ 5.38) (p < 0.000, group 1 versus control group; p < 0.567, group 2 versus control group).
Follow-up. After a mean follow-up interval of 8 months (range 2 to 18), three patients (18%) from group 1 had documented recurrent paroxysmal atrial fibrillation; the respective P wave duration in these patients was 150.5, 171.0 and 139.0 ms ( Table 1 ). There were no arrhythmia recurrences in group 2.
Discussion
The clinical incidence rate of paroxysmal atrial fibrillation in patients with Wolff-Parkinson-White syndrome has been reported (1) to range from 12% to 32%. However, the reasons for this high rate are not clear. It has been suggested (8) that the association of mechanical factors such as atrial stretch, hypoxemia and AV reciprocating tachycardia may be precipitating factors. Other studies (9,10) have suggested that fast retrograde conduction over an anomalous pathway or the presence of atrial premature beats during orthodromic reciprocating tachycardia may be precipitating factors for the development of acute episodes of atrial fibrillation. These two situations could induce atrial activation during incomplete recovery of the atrial tissue, leading to the initiation of intraatrial reentry, and subsequent atrial fibrillation. The de-creased incidence of paroxysmal atrial fibrillation reported after surgical (11) or catheter (12) elimination of the accessory pathway conduction suggests participation of such conduction in the genesis of this atrial tachyarrbythmia. All these findings support the hypothesis that the anomalous pathway mediated the episodes of atrial fibrillation. However, after successful elimination of the anomalous connection, some patients may still have spontaneous sustained episodes of atrial fibrillation with no evidence of accessory pathway conduction, even after adenosine infusion. In the present study, the incidence of recurrent paroxysmal atrial fibrillation after radiofrequency ablation was 17.6%, a fact suggesting that the accessory pathway is not always the main cause of atrial fibrillation. Furthermore, as observed in our patients, successful ablation of the accessory pathway, performed during paroxysmal atrial fibrillation, does not result in termination of the fibrillatory episodes ( Fig. 1) , even after 60 rain of the procedure. Thus, the anomalous pathway is probably responsible for initiation of the acute episodes of atrial fibrillation but not for their maintenance.
Intraatrial conduction disturbances have been demonstrated (9) in patients with the Wolff-Parkinson-White syndrome and paroxysmal atrial fibrillation assessed by electrophysiologic studies. Some patients with ventricular preexcitation exhibit ECG P wave morphologic disturbances, and the causes of such alterations have been extensively discussed (13) . In several patients, the P waves are distinctly notched, suggesting the presence of intraatrial conduction disturbances. Thus, as previously discussed, it is very possible that the anomalous pathway plays a role in the initiation of atrial fibrillation by rapid retrograde conduction of the electrical impulse during AV reciprocating tachycardia so that it reaches the atria during the vulnerable period. However, not only the presence of the anomalous connection itself but the associated delayed conduction in the atrial tissue could facilitate and perpetuate reentry (10) .
The delayed intraatrial conduction time represents an important factor precipitating acute episodes of atrial fibrillation (14) . It has been demonstrated (15) that the inducibility of atrial fibrillation before and after radiofrequency ablation of the anomalous pathway is independent of the presence of the accessory connection and similar to that in the general population. Thus, supporting the results obtained from electrophysiologic studies (10) , our data strongly suggest the presence of delayed atrial activation in patients with the Wolff-Parkinson-White syndrome and paroxysmal atrial fibrillation. Using a more sensitive technique to study atrial activation time, we observed a higher incidence of conduction delay in these patients. In addition, no patient had an enlarged left atrium as assessed by echocardiography. Thus, it is interesting to speculate that, from the same anatomic substratum (conduction delay), the episodes of atrial fibrillation would be more frequent in patients with the Wolff-Parkinson-White syndrome than in the general population because the presence of the accessory pathway itself could facilitate initiation of the fibrillatory state. The conduction delay in the atrial tissue would further allow perpetuation of atrial reentry and the fibrillatory mechanisms. This hypothesis is supported by the greater increase in P wave duration seen in patients in group I than in group 2 when the signal-averaged P wave and the P wave in lead II were compared (50.15 ± 5.88 vs. 34.36 ± 5.35 ms, p < 0.000). These findings suggest that in patients with paroxysmal atrial fibrillation, the impairment in atrial conduction is highlighted by the low amplitude signals that are detected by the averaging process.
Limitations of the study. One could argue the consequences of radiofrequency application at the AV groove and its possible implications for the results observed here. However, the majority of patients had a left-sided connection and consequently the energy was delivered at the ventricular insertion of the pathway, during a retrograde aortic approach. Radiofrequeney lesions are small (4 to 5 ram, depending on the tip of the catheter used during the procedure) (16) and could not interfere with P wave duration. Indeed, all patients enrolled in this study underwent a Doppler echocardiographic study before and after the ablation in which no valvular insutficiency was diagnosed. In addition, the results obtained when we analyzed only patients with a left-sided anomalous pathway were almost the same as those observed in the total group, and there were no correlations in either group between P wave duration and the number of radiofrequency applications or the amount of energy delivered.
Clinical implications. To date, with clinical paroxysmal atrial fibrillation has developed in 3 of 17 patients after ablation; all 3 patients had a P wave duration > 135.0 ms, thus reflecting the accuracy of the signal-averaged P wave method for detecting patients likely to have this type of atrial arrhyth-mia. Unfortunately, the method has limited clinical application, because the delta wave overshadows the correct measurement of P wave duration. However, as a noninvasive procedure, it can contribute to the understanding of the complex mechanisms involved in the genesis of paroxysmal atrial fibrillation.
